Guangdong Xinxiang Pharmaceutical Co., Ltd.

1) To objectively evaluate the clinical efficacy of Sanqi Huoluo Ointment in the treatment of subjects with acute closed soft tissue injury (Qi stagnation and blood stasis syndrome) with pain improvement as the primary efficacy indicator and TCM syndrome and functional recovery of the injured part as the secondary efficacy evaluation criteria; 2) To objectively evaluate the safety of Sanqi Huoluo Ointment based on laboratory test indicators, local skin allergies and irritation reactions and other adverse events. 3) To explore the reasonable dosage and course of treatment of Sanqi Huoluo Ointment.